TradingKey

关于 Bausch + Lomb Corp 公司

Bausch + Lomb Corporation 是一家眼保健公司。其业务分为三个部门：视力保健、制药和外科。视力保健部门包括隐形眼镜和消费者眼保健业务，包括隐形眼镜护理产品、非处方眼药水和眼部维生素。制药部门包括用于术后治疗和多种眼部疾病治疗的仿制药产品，例如青光眼、眼部炎症、眼高压、干眼症和视网膜疾病。外科部门包括用于治疗白内障、角膜和玻璃体以及视网膜眼部疾病的医疗器械设备、耗材、仪器和技术，其中包括输送系统、晶状体乳化设备和其他用于白内障手术的手术器械和设备。其品牌包括 PreserVision、Biotrue、Artelac、Alaway、Mioclear、Ocuvite、ScoutPro、XIIDRA、Vyzulta、Lotemax、Prolensa、Minims、INFUSE 等。

公司简介

公司代码BLCO

公司名称Bausch + Lomb Corp

上市日期May 06, 2022

CEOMr. Brenton L. (Brent) Saunders, J.D.

员工数量13500

证券类型Ordinary Share

年结日May 06

公司地址520 Applewood Crescent

城市VAUGHAN

上市交易所NYSE Consolidated

国家Canada

邮编L4K 4B4

电话19082552864

网址https://ir.bausch.com/

公司代码BLCO

上市日期May 06, 2022

CEOMr. Brenton L. (Brent) Saunders, J.D.

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Brenton L. (Brent) Saunders, J.D.

Chairman of the Board, Chief Executive Officer

352.13K

+162.32%

Mr. Brett M. Icahn

Independent Director

75.84K

+85.85%

Mr. Luc Bonnefoy

President - Surgical

71.22K

-2.95%

Mr. Russel C. Robertson

Independent Director

64.91K

+53.22%

Dr. Andrew Charles Von Eschenbach, M.D.

Independent Director

62.09K

+55.01%

Dr. Yehia Hashad, M.D.

Executive Vice President - Research & Development, Chief Medical Officer

50.46K

-5.33%

Mr. A. Robert D. Bailey, J.D.

Executive Vice President, Chief Legal Officer

--

Ms. Karen L. Ling

Independent Director

--

Mr. Gary Hu

Independent Director

--

Ms. Sarah B. Kavanagh

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Brenton L. (Brent) Saunders, J.D.

Chairman of the Board, Chief Executive Officer

352.13K

+162.32%

Mr. Brett M. Icahn

Independent Director

75.84K

+85.85%

Mr. Luc Bonnefoy

President - Surgical

71.22K

-2.95%

Mr. Russel C. Robertson

Independent Director

64.91K

+53.22%

Dr. Andrew Charles Von Eschenbach, M.D.

Independent Director

62.09K

+55.01%

Dr. Yehia Hashad, M.D.

Executive Vice President - Research & Development, Chief Medical Officer

50.46K

-5.33%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Devices

448.00M

39.40%

OTC

409.00M

35.97%

Pharmaceuticals

222.00M

19.53%

Branded and other Generics

54.00M

4.75%

Other revenues

4.00M

0.35%

暂无数据

业务

地区

业务USD

名称

营收

占比

Devices

448.00M

39.40%

OTC

409.00M

35.97%

Pharmaceuticals

222.00M

19.53%

Branded and other Generics

54.00M

4.75%

Other revenues

4.00M

0.35%

股东统计

更新时间: 7月29日周二

持股股东

股东类型

持股股东

占比

Bausch Health Companies Inc

87.75%

Deutsche Bank Securities Inc.

0.99%

Icahn Associates Corporation

0.99%

Alberta Investment Management Corporation

0.92%

GoldenTree Asset Management, LP

0.64%

Other

8.72%

持股股东

占比

Bausch Health Companies Inc

87.75%

Deutsche Bank Securities Inc.

0.99%

Icahn Associates Corporation

0.99%

Alberta Investment Management Corporation

0.92%

GoldenTree Asset Management, LP

0.64%

Other

8.72%

股东类型

持股股东

占比

Corporation

87.75%

Hedge Fund

4.16%

Investment Advisor/Hedge Fund

2.86%

Research Firm

1.52%

Investment Advisor

1.21%

Sovereign Wealth Fund

0.92%

Individual Investor

0.45%

Pension Fund

0.25%

Family Office

0.18%

Other

0.71%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

263

350.73M

99.13%

-18.03M

2025Q1

273

350.60M

99.12%

-19.40M

2024Q4

262

347.48M

98.58%

-23.77M

2024Q3

257

349.38M

99.14%

-19.72M

2024Q2

260

352.10M

99.92%

-21.43M

2024Q1

247

349.79M

99.91%

-25.18M

2023Q4

237

351.31M

100.35%

-21.66M

2023Q3

219

355.43M

101.52%

-16.80M

2023Q2

207

357.28M

102.06%

-12.23M

2023Q1

194

356.91M

101.97%

-11.11M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Bausch Health Companies Inc

310.45M

87.77%

--

Mar 24, 2025

Deutsche Bank Securities Inc.

3.50M

0.99%

+3.50M

--

Mar 31, 2025

Icahn Associates Corporation

3.50M

0.99%

--

Mar 31, 2025

Alberta Investment Management Corporation

3.27M

0.92%

+258.00K

+8.58%

Mar 31, 2025

GoldenTree Asset Management, LP

2.25M

0.64%

+516.07K

+29.79%

Mar 31, 2025

Maple Rock Capital Partners, Inc.

1.97M

0.56%

-1.20M

-37.84%

Mar 31, 2025

D. E. Shaw & Co., L.P.

1.88M

0.53%

-6.18K

-0.33%

Mar 31, 2025

Whitebox Advisors, L.L.C.

1.62M

0.46%

+179.78K

+12.46%

Mar 31, 2025

River Road Asset Management, LLC

1.59M

0.45%

+85.05K

+5.64%

Mar 31, 2025

Arrowstreet Capital, Limited Partnership

1.52M

0.43%

+301.42K

+24.74%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

Ballast Small/Mid Cap ETF

1.28%

BNY Mellon US Small Cap Core Equity ETF

0.03%

Invesco RAFI Developed Mkts ex-US SM ETF

0.02%

Schwab Fundamental International Small Equity ETF

0.01%

Fidelity Sustainable High Yield ETF

0%

QRAFT AI-Enhanced US Large Cap ETF

0%

DFA Dimensional Intl Sustainability Core 1 ETF

0%

Goldman Sachs MarketBeta US 1000 Equity ETF

0%

Invesco Zacks Mid-Cap ETF

0%

First Trust US Equity Opportunities ETF

0%

Ballast Small/Mid Cap ETF

占比1.28%

BNY Mellon US Small Cap Core Equity ETF

占比0.03%

Invesco RAFI Developed Mkts ex-US SM ETF

占比0.02%

Schwab Fundamental International Small Equity ETF

占比0.01%

Fidelity Sustainable High Yield ETF

占比0%

QRAFT AI-Enhanced US Large Cap ETF

占比0%

DFA Dimensional Intl Sustainability Core 1 ETF

占比0%

Goldman Sachs MarketBeta US 1000 Equity ETF

占比0%

Invesco Zacks Mid-Cap ETF

占比0%

First Trust US Equity Opportunities ETF

占比0%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Bausch + Lomb Corp

13.790USD

Bausch + Lomb Corp

13.790

概览

公司

财务